P

Pannex Therapeutics Inc.

3 employees

Pannex Therapeutics is pioneer in developing the first multi-pathway approach to treat cancer,

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Small molecules
Monoclonal Antibodies
Pharmaceutical
Drug Discovery
Clinical Trials
Pannexin 1
Neurology
Neuroscience
Innovation
Project Management
Medical
Enterpreneurship
Drug Development
InSilico
Nanotechnology
Non-Clinical Trials
Chronic Pain

Date founded

2021

Funding rounds raised

P

Pannex Therapeutics Inc. raised undisclosed on May 23, 2023

Investors: IndieBio and SOSV - The Accelerator VC

P

Pannex Therapeutics Inc. raised undisclosed on June 21, 2022

Investors: IndieBio and SOSV - The Accelerator VC

P

Pannex Therapeutics Inc. raised undisclosed on October 12, 2021

Investors: SOSV - The Accelerator VC

P

Pannex Therapeutics Inc. raised undisclosed on October 12, 2021

Investors: SOSV - The Accelerator VC

FAQ